Act Co., Ltd. manufactures, develops, and sells the inorganic coagulant for wastewater treatment "Suimu," the neutralizing agent for alkaline wastewater "Yumu," and the small-scale coagulation separation filtration device "ACT-200." In particular, our flagship product "Suimu" meets the following expectations: • We want to reduce the total cost of wastewater treatment by 50-70%, rather than just focusing on the surface-level chemical prices. • We want to address difficult-to-treat wastewater, such as heavy metals and water-based paints. • We aim to go beyond mere compliance with minimum regulations and strive for a fundamental reduction in environmental impact as part of our ESG management. • We want to reduce the burden on site by using chemicals with high handling ease that can be used without specialized knowledge. Additionally, our high reliability, demonstrated by certifications from the Ministry of Land, Infrastructure, Transport and Tourism and the Ministry of Agriculture, Forestry and Fisheries, as well as our adoption for treating radioactive contaminated water after the Fukushima nuclear accident, is one of the reasons for our product's introduction. In recent years, we have seen an increase in inquiries from companies stating that "the treatment effect of conventional coagulants has become insufficient," and in response to such needs, we are prototyping "custom-made coagulants" tailored to the characteristics of wastewater. Furthermore, the prototyping and sample provision of "custom-made coagulants" will be provided free of charge. If you are interested, please feel free to contact us.